Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Vaccination with autologous HIV-1-pulsed DCs feasible in HIV

March 4, 2010

Phase III study supports once-daily dosing of darunavir/ritonavir in HIV-1 infection

March 2, 2010

C5A inhibits HIV-1 and HSV in preclinical studies

March 1, 2010

Vicriviroc does not meet primary endpoint in two phase III trials in HIV

March 1, 2010

QNL-111 shown to inhibit HIV-1 DNA integration

March 1, 2010

Truvada well tolerated in HIV-1-infected pregnant women and neonates

March 1, 2010

FDA sets tentative new date for review of tesamorelin NDA

Feb. 26, 2010

Bristol-Myers Squibb discovers novel anti-HIV agents

Feb. 26, 2010

Prime/boost HIV vaccine shows high immunogenicity in healthy volunteers in phase I/II trial

Feb. 26, 2010

Chemokine CCR5 receptor antagonist TBR-652 well tolerated in HIV-1-infected patients

Feb. 26, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...